- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine engineering for targeted cancer immunotherapy
Authors
Keywords
-
Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 62, Issue -, Pages 43-52
Publisher
Elsevier BV
Online
2021-03-07
DOI
10.1016/j.cbpa.2021.01.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-23 engineering improves CAR T cell function in solid tumors
- (2020) Xingcong Ma et al. NATURE BIOTECHNOLOGY
- Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
- (2020) Aslan Mansurov et al. Nature Biomedical Engineering
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
- (2020) Claire Gorby et al. Science Signaling
- Immunocytokines are a promising immunotherapeutic approach against glioblastoma
- (2020) Tobias Weiss et al. Science Translational Medicine
- De novo design of potent and selective mimics of IL-2 and IL-15
- (2019) Daniel-Adriano Silva et al. NATURE
- Therapeutic Protein PEPylation: The Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation
- (2019) Yingqin Hou et al. ACS Central Science
- Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
- (2019) Dario Neri Cancer Immunology Research
- Immunoreceptor Engineering and Synthetic Cytokine Signaling for Therapeutics
- (2019) Jürgen Scheller et al. TRENDS IN IMMUNOLOGY
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- (2019) Jun Ishihara et al. Science Translational Medicine
- Enzyme-Activatable Interferon–Poly(α-amino acid) Conjugates for Tumor Microenvironment Potentiation
- (2019) Hao Wang et al. BIOMACROMOLECULES
- Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
- (2019) Noor Momin et al. Science Translational Medicine
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy
- (2019) Koichi Sasaki et al. Science Advances
- A strategy for the selection of monovalent antibodies that span protein dimer interfaces
- (2019) Jamie B. Spangler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy
- (2019) John-Michael Williford et al. Science Advances
- Macrocyclization of Interferon–Poly(α-amino acid) Conjugates Significantly Improves the Tumor Retention, Penetration, and Antitumor Efficacy
- (2018) Yingqin Hou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
- (2018) Li Tang et al. NATURE BIOTECHNOLOGY
- Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
- (2018) Jonathan T. Sockolosky et al. SCIENCE
- Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
- (2018) Michael Dougan et al. Cancer Immunology Research
- Reprogramming immune proteins as therapeutics using molecular engineering
- (2018) Rakeeb Kureshi et al. Current Opinion in Chemical Engineering
- Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
- (2018) Cornelia Hutmacher et al. ADVANCED DRUG DELIVERY REVIEWS
- Mapping Determinants of Cytokine Signaling via Protein Engineering
- (2018) Claire Gorby et al. Frontiers in Immunology
- Recent Advances in Anti-cancer Protein/Peptide Delivery
- (2018) Xun Liu et al. BIOCONJUGATE CHEMISTRY
- Polymer–drug conjugate therapeutics: advances, insights and prospects
- (2018) Iriny Ekladious et al. NATURE REVIEWS DRUG DISCOVERY
- Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
- (2017) Jun Ishihara et al. Science Translational Medicine
- The Common Cytokine Receptor γ Chain Family of Cytokines
- (2017) Jian-Xin Lin et al. Cold Spring Harbor Perspectives in Biology
- Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
- (2017) Rodrigo Vazquez-Lombardi et al. Nature Communications
- Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
- (2017) Oladapo O. Yeku et al. Scientific Reports
- CAR T Cells Releasing IL-18 Convert to T-Bet high FoxO1 low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
- (2017) Markus Chmielewski et al. Cell Reports
- Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
- (2017) Giedre Krenciute et al. Cancer Immunology Research
- Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors
- (2017) A. Kunert et al. OncoImmunology
- Site-specific in situ growth of an interferon-polymer conjugate that outperforms PEGASYS in cancer therapy
- (2016) Jin Hu et al. BIOMATERIALS
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- Immunocytokines for cancer treatment: past, present and future
- (2016) Dario Neri et al. CURRENT OPINION IN IMMUNOLOGY
- Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions
- (2016) Franziska Bootz et al. DRUG DISCOVERY TODAY
- A Concise Approach to Site-Specific Topological Protein–Poly(amino acid) Conjugates Enabled by in Situ-Generated Functionalities
- (2016) Yingqin Hou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
- (2016) N. Arenas-Ramirez et al. Science Translational Medicine
- Insights into Cytokine–Receptor Interactions from Cytokine Engineering
- (2015) Jamie B. Spangler et al. Annual Review of Immunology
- A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy
- (2015) Hui Liang et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
- (2015) Yu Mima et al. MOLECULAR PHARMACEUTICS
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies
- (2015) George D. Kalliolias et al. Nature Reviews Rheumatology
- Antibody fusions with immunomodulatory proteins for cancer therapy
- (2015) Dafne Müller PHARMACOLOGY & THERAPEUTICS
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Beyond Poly(ethylene glycol): Linear Polyglycerol as a Multifunctional Polyether for Biomedical and Pharmaceutical Applications
- (2014) Anja Thomas et al. BIOMACROMOLECULES
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Side Effects of Cytokines Approved for Therapy
- (2014) Brian A. Baldo DRUG SAFETY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Therapeutic Protein–Polymer Conjugates: Advancing Beyond PEGylation
- (2014) Emma M. Pelegri-O’Day et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
- (2014) Samir Mitragotri et al. NATURE REVIEWS DRUG DISCOVERY
- Antibody-Cytokine Fusion Proteins for Treatment of Cancer: Engineering Cytokines for Improved Efficacy and Safety
- (2014) Patricia A. Young et al. SEMINARS IN ONCOLOGY
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- Trehalose Glycopolymers for Stabilization of Protein Conjugates to Environmental Stressors
- (2012) Rock J. Mancini et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- A Low-Toxicity IL-2-Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity
- (2011) S. D. Gillies et al. CLINICAL CANCER RESEARCH
- Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity
- (2011) Andrew J. Keefe et al. Nature Chemistry
- IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
- (2010) J. C. Markley et al. BLOOD
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
- (2010) Matthias T Stephan et al. NATURE MEDICINE
- The Collagen Family
- (2010) S. Ricard-Blum Cold Spring Harbor Perspectives in Biology
- Collagen density promotes mammary tumor initiation and progression
- (2008) Paolo P Provenzano et al. BMC Medicine
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Structural Biology of Shared Cytokine Receptors
- (2007) Xinquan Wang et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More